Programme

2017 Themes:

1. Imaging MS and NMOSD (both diagnostic and research)
2. Mechanisms of CNS Inflammation (Disease Models, Basic Science, Laboratory Investigations)
3. Therapeutics in Asia (Not only Medications, but the Differences Compared with the Western Situation)
4. Environmental Factors in MS/NMOSD (e.g. Gut Microbiome, Sunlight, Smoking, etc., Interaction with Genetics)

Thursday, 23 November 2017
Grand Ballroom
12:30-14:00 European Charcot Foundation Symposium
How to Improve Recovery in MS
Chairpersons: William Carroll (Australia)
1. Remyelination Strategy: Its Basic Science and Clinical Application
 - Hans-Peter Hartung (Germany)
2. Symptomatic Treatment
 - Kazuo Fujihara (Japan)
3. New Strategies for Rehabilitation
 - Giancarlo Comi (Italy)
4. Neuromodulation to Enhance Recovery in MS
 - Letizia Leocani (Italy)
14:00-14:30 Coffee Break  
14:30-14:45 Opening Ceremony
1. Welcome Address by the Chairman, 2017 Local Organising Committee
 - Nguyen Thi Hung (Vietnam)
2. Opening Address by the President, PACTRIMS
 - Takahiko Saida (Japan)
3. Special Remarks by the Vice Minister of Health, Ministry of Health (Vietnam)
 - Le Quang Cuong (Vietnam)
14:45-15:55 Opening Symposium: Main Symposium-1
How Genes and Germs Influence CNS Inflammation?
Part 1. How Genetic Factors Influence Neuroinflammation?
Chairpersons: Bruce Taylor (Australia) and Wei Qiu (China)
1. Keynote Lecture: From Genetic Association to Functional Studies in MS
 - Hanne Flinstad Harbo (Norway)
2. Genetic Risk Factors for MS in Non-Caucasian Populations
 - Noriko Isobe (Japan)
15:55-16:05 Coffee Break
16:05-17:15 Opening Symposium: Main Symposium-1
How Genes and Germs Influence CNS Inflammation?
Part 2. How Environmental Factors Influence Neuroinflammation?
Chairpersons: William Carroll (Australia) and Masoud Etemadifar (Iran)
3. The Microbiota and MS
 - Allan Kermode (Australia)
4. Underlying Mechanisms for How Environmental Allergens Modulate Neuroinflammation
 - Jun-ichi Kira (Japan)
17:15-17:30 Coffee Break
17:30-19:00 Merck Sponsored Symposium
Changing the Paradigm in the Treatment of MS in Asia Pacific
19:30-21:00 Welcome Reception @ Purple Jade, 1F, InterContinental Asiana Saigon
Friday, 24 November 2017
 Grand Ballroom
8:30-10:00 Sanofi Genzyme Sponsored Symposium
New Treatment Options for Multiple Sclerosis – How to Find the Right Approach for Each Patient?
10:00-10:30 Coffee Break
10:30-12:30 Oral Presentation-1 (10:30-11:15)
Chairperson: Alvin Seah (Singapore)
(O-1)
Contribution of Cortical Lesions to Cognitive Dysfunction in Japanese Patients with Multiple Sclerosis
 - Koji Shinoda (Japan)
(O-2)
Narrowband UVB Phototherapy for Clinically Isolated Syndrome: Delivering the Benefits of All UVB-Induced Molecules
 - Marzena Fabis-Pedrini (Australia)
(O-3)
Restoration of Regulatory B Cell Deficiency Following Alemtuzumab Therapy in Patients with Active Multiple Sclerosis
 - Yeseul Kim (Republic of Korea)
Oral Presentation-2 (11:15-12:00)
Chairperson: Byung-Jo Kim (Republic of Korea)
(O-4)
Nationwide Epidemiological Study of Neuromyelitis Optica in Japan
 - Katsuichi Miyamoto (Japan)
(O-5)
Intestinal Microbiota Distinguish Neuromyelitis Optica Patients from Healthy Individuals in a Chinese Pilot Study
 - Jun Li Gong (China)
(O-6)
Bidirectional Degeneration in The Visual Pathway in Neuromyelitis Optica Spectrum Disorder (NMOSD)
 - Decai Tian (China)
Two Minute Oral Presentation of Selected Posters (12:00-12:30)
Chairperson: Makoto Matsui (Japan)
(O-7)
Brain Volume Loss Is Present in Japanese Patients with Multiple Sclerosis with No Evidence of Disease Activity
 - Hiroaki Yokote (Japan)
(O-8)
Dynamic Expression of Circulating MicroRNA-155 in Plasma of Patients with Multiple Sclerosis
 - Qin Bing (China)
(O-9)
Deviated Repertoire of gd T Cells is Associated with Disease Severity of Multiple Sclerosis
 - Maimaitijiang Guzailiayi (Japan)
(O-10)
De Novo Trigeminal Neuralgia Induced by Dalfampridine (4-aminopyridine) :3 Cases
 - Mehmet Ozmenoglu (Turkey)
(O-11)
Neuromyelitis Optica: An 18-case Experience at Ho Chi Minh City University Medical Center in Vietnam
 - Thi Vu Thuy (Vietnam)
(O-12)
Ethnic Differences in Clinical Manifestation of Neuromyelitis Optica Spectrum Disorder
 - Su-Hyun Kim (Republic of Korea)
(O-13)
Discrimination of Spinal Cord Sarcoidosis from Neuromyelitis Optica Spectrum Disorder or Spondylotic Myelopathy
 - Hiroshi Kuroda (Japan)
(O-14)
Different Features between Pediatric-Onset and Adult-Onset Patients Who Are Seropositive For MOG-IgG: A Multicenter Study in South China
 - Lu Chen (China)
(O-15)
Cerebrospinal Fluid-Actin Related Protein 2/3 Complex Subunit 4 as an Astrocytic Foot Process Damage Marker of Aquaporin-4-Igg Positive Neuromyelitis Optica Spectrum Disorders
 - Shuhei Nishiyama (Japan)
(O-16)
Choroid Plexitis in Neuromyelitis Optica Spectrum Disorder
 - YeoJin Oh (Republic of Korea)
(O-17)
Oligodendroglia-Specific Connexin 47 Deletion Induced Relapse-Remitting EAE Model Mice
 - Ryo Yamasaki (Japan)
12:30-13:30 Lunch at Market 39, Lobby & Purple Jade, 1F, InterContinental Asiana Saigon & Poster Viewing
13:30-14:10 10th PACTRIMS Anniversary Lecture
Chairperson: Helmut Butzkueven (Australia)
The Impact of Registries for MS and NMOSD Research and Care
 - Jan Hillert (Sweden)
14:10-14:20 Coffee Break
14:20-15:20 Presidential Symposium: Main Symposium-2
Therapeutics and Health Care Policies for MS and NMOSD in Asia: Present Status and Road Blocks to Change
Chairpersons: Le Van Tuan (Vietnam) and Ching-Piao Tsai (Taiwan)
1. Multiple Sclerosis: Challenge on Diagnostic and Management in Vietnam
 - Nguyen Thi Hung (Vietnam)
2. Therapeutics and Health Care Policies for MS and NMOSD in Indonesia
 - Riwanti Estiasari (Indonesia)
3. Therapeutics and Health Care Policies for MS and NMOSD in Malaysia
 - Shanthi Viswanathan (Malaysia)
4. Therapeutics and Health Care Policies for MS and NMOSD in Asia: Present Status and Road Blocks to Change – From China
 - Fu-Dong Shi (China)
15:20-15:50 Coffee Break & Poster Viewing
15:50-17:20 PACTRIMS Teaching Session-1: Main Symposium-4
Differential Diagnosis for MS/NMOSD/Autoimmune Encephalitis/Other Mimickers: An Interactive Case Discussion
Chairpersons: Ho Jin Kim (Republic of Korea) and Naraporn Prayoonwiwat (Thailand)
1. Autoimmune Encephalitis
    – Lekha Pandit (India)
2. Neuro-Behcet Disease
   – Ha Young Shin (Republic of Korea)
3. Anti-MOG Antibody Syndrome in Thai Patients
   – Sasitorn Siritho (Thailand)
4. (O-18) Case Presentation from The Ordinary Submissions-1: Susac’s Syndrome in A Patient Misdiagnosed with Multiple Sclerosis
   – Jong Sze Chin (Singapore)
5. (O-19) Case Presentation from The Ordinary Submissions-2: Fingolimod-Associated PML with Mild Immune Reconstitution Inflammatory Syndrome in Multiple Sclerosis
   – Tatsuro Misu (Japan)
18:30-22:00 Presidential Dinner @ Cham Charm
Friday, 24 November 2017
Phu Quoc (Breakout Session)
14:20-15:20 Main Symposium-3
Imaging MS and NMO Lesions by Conventional MRI and Novel Methodologies
Part 1. Imaging MS and NMO Lesions by Conventional MRI
Chairpersons: Ernest Willoughby (New Zealand) and Jen-Jen Su (Taiwan)
1. Keynote Lecture: Imaging MS Lesions and Treatment Effects by Conventional MRI
 - Ernst-Wilhelm Radue (Switzerland)
2. Imaging NMOSD Lesions and Treatment Effects by Conventional MRI 
 - Su-Hyun Kim (Republic of Korea)
15:20-15:50 Coffee Break & Poster Viewing
15:50-17:20 Main Symposium-3
Imaging MS and NMO Lesions by Conventional MRI and Novel Methodologies
Part 2. Imaging Tissue Damage and Repair in MS and NMO by Novel Methodologies
Chairpersons: Michael Barnett (Australia) and Yaou Liu (China)
3. Keynote Lecture: Imaging Tissue Damage and Degeneration in MS and NMOSD
 - Olga Ciccarelli (UK)
4. Imaging Remyelination by q-Space Myelin Map in MS and NMOSD
 - Jin Nakahara (Japan)
5. Imaging Plasticity in MS and NMOSD
 - Yaou Liu (China) 
Saturday 25 November 2017
Grand Ballroom
8:30-10:00 PACTRIMS Teaching Session-2: Main Symposium-5
Neuroimaging Teaching Course: How to Make Good Use of MRI in Clinical Practice for CNS Demyelinating Disease
Chairpersons: Anthony Traboulsee (Canada) and Joyce Joseph (Malaysia)
1. How to Use MRI Diagnostic Criteria for MS and NMOSD
– Frederik Barkhof (The Netherlands)
2. How to Use MRI for Differential Diagnosis of MS and NMOSD
– Olga Ciccarelli (UK)
2. How to Use MRI For Monitoring Treatment Effects in MS and NMOSD
– Ernst-Wilhelm Radue (Switzerland)
10:00-10:30 Coffee Break & Poster Viewing
10:30-11:40 Main Symposium-6
Understanding Autoantibody-mediated Neuro-inflammation
Part 1. Autoimmunity Against Astrocytes
Chairpersons: Akio Suzumura (Japan) and Trevor Kilpatrick (Australia)
1. Keynote Lecture: A Novel Mechanism of AQP4 Antibody-mediated Demyelination
– Alan S. Verkman (USA)
2. Mechanism and Spectrum of Autoimmune GFAP Meningoencephalomyelitis
– Vanda A. Lennon (USA) 
11:40-12:00 Coffee Break
12:00-13:00 Main Symposium-6
Understanding Autoantibody-mediated Neuro-inflammation
Part 2. Autoimmunity Against Myelinating Cells
Chairpersons: Byoung Joon Kim (Republic of Korea) and Kevin Tan (Singapore)
3. Mechanism and Spectrum of MOG Antibody-mediated Encephalomyelitis
– Ichiro Nakashima (Japan)
4. IgG4 Anti-neurofascin 155 Antibody in Peripheral and Central Demyelination
– Ryo Yamasaki (Japan)
13:00-13:10 Closing and Award Ceremony
1. Award Ceremony
 - Jun-ichi Kira (Japan)
2. Closing Remarks by the Vice President, PACTRIMS
 - William Carroll (Australia)

 

*The program is subject to change.